Neumann is director of the Center for the Evaluation of Value and Risk (CEVR) at Tufts Medical Center. Crummer is a research assistant at CEVR. Kaltenboeck is a principal and head of prescription drug ...
The US Food and Drug Administration (FDA) accepts a wide variety of applications into its Emerging Technologies Program (ETP), and is not just focused on continuous manufacturing, said Joel Welch, ...
FDA Finalizes Guidance on Emerging Manufacturing Tech Program The US Food and Drug Administration (FDA) on Thursday finalized its guidance detailing how drugmakers can participate in the agency's ...
The Situation: In September 2024, the U.S. Department of Justice ("DOJ" or "Department") announced updates to its Evaluation of Corporate Compliance Programs guidance covering three primary areas: (1) ...
N-Sorb leverages Aptar CSP Technologies’ proven 3-Phase Activ-Polymer™ platform technology to address the pressing issue of N-nitrosamine impurities in pharmaceuticals. These impurities, classified as ...